𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Variable responses to rituximab treatment in neuromyelitis optica (Devic’s disease)

✍ Scribed by M. Capobianco; S. Malucchi; A. di Sapio; F. Gilli; A. Sala; R. Bottero; F. Marnetto; C. Doriguzzi Bozzo; A. Bertolotto

Publisher
Springer Milan
Year
2007
Tongue
English
Weight
158 KB
Volume
28
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can CSF biomarkers or pre-treatment prog
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
✍ Å. K. Wallin; O. Hansson; K. Blennow; E. Londos; L. Minthon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract ## Objective The main objective of this study was to investigate possible predictors of response to cholinesterase inhibitor (ChEI) treatment, including pre‐treatment progression rates and levels of the cerebrospinal fluid (CSF) biomarkers. A secondary objective was to evaluate whether

Patient predictors of response to treatm
Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study
✍ Martin Steinberg; Cynthia A. Munro; Quincy Samus; Peter V.Rabins; Jason Brandt; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

## Abstract ## Objective To investigate patient predictors of response to treatment of Major Depressive Episode (MDE) in Alzheimer's disease (AD). ## Methods Forty‐four outpatients with AD and MDE were randomized to receive either sertraline or placebo in a 12‐week placebo‐controlled, flexible‐d